DAFNA Capital Management as of Dec. 31, 2022
Portfolio Holdings for DAFNA Capital Management
DAFNA Capital Management holds 79 positions in its portfolio as reported in the December 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Spdr S&p Biotech Etf Etf (XBI) | 13.2 | $47M | 566k | 83.00 | |
| Stereotaxis Com New (STXS) | 8.0 | $28M | 14M | 2.07 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 4.5 | $16M | 130k | 122.13 | |
| Karuna Therapeutics Ord | 4.0 | $14M | 72k | 196.50 | |
| Ishares Nasdaq Biotech Indx Etf (IBB) | 3.8 | $14M | 103k | 131.29 | |
| Iveric Bio | 3.7 | $13M | 606k | 21.41 | |
| Xenon Pharmaceuticals (XENE) | 3.5 | $13M | 316k | 39.43 | |
| Blueprint Medicines (BPMC) | 3.2 | $11M | 261k | 43.81 | |
| Revolution Medicines (RVMD) | 3.2 | $11M | 478k | 23.82 | |
| Syndax Pharmaceuticals (SNDX) | 3.2 | $11M | 447k | 25.45 | |
| Neurocrine Biosciences (NBIX) | 2.5 | $8.7M | 73k | 119.44 | |
| Ideaya Biosciences (IDYA) | 2.4 | $8.5M | 468k | 18.17 | |
| Cytokinetics Com New (CYTK) | 2.4 | $8.4M | 184k | 45.82 | |
| Dex (DXCM) | 2.2 | $7.6M | 68k | 113.24 | |
| Sage Therapeutics (SAGE) | 1.9 | $6.9M | 180k | 38.14 | |
| Edgewise Therapeutics (EWTX) | 1.9 | $6.9M | 767k | 8.94 | |
| Nurix Therapeutics (NRIX) | 1.8 | $6.2M | 567k | 10.98 | |
| Adicet Bio (ACET) | 1.6 | $5.6M | 632k | 8.94 | |
| Fate Therapeutics (FATE) | 1.6 | $5.6M | 551k | 10.09 | |
| Biohaven (BHVN) | 1.5 | $5.5M | 393k | 13.88 | |
| Morphic Hldg (MORF) | 1.5 | $5.2M | 196k | 26.75 | |
| Alector (ALEC) | 1.4 | $4.9M | 532k | 9.23 | |
| Viking Therapeutics (VKTX) | 1.4 | $4.9M | 522k | 9.40 | |
| Apellis Pharmaceuticals (APLS) | 1.2 | $4.3M | 83k | 51.71 | |
| Merus N V (MRUS) | 1.2 | $4.2M | 270k | 15.47 | |
| Kalvista Pharmaceuticals (KALV) | 1.2 | $4.2M | 616k | 6.76 | |
| 89bio (ETNB) | 1.2 | $4.1M | 324k | 12.73 | |
| Cardiovascular Systems | 1.1 | $3.9M | 287k | 13.62 | |
| Dice Therapeutics | 1.1 | $3.9M | 124k | 31.20 | |
| F-star Therapeutics | 1.0 | $3.6M | 577k | 6.32 | |
| Bicycle Therapeutics Sponsored Ads (BCYC) | 1.0 | $3.6M | 122k | 29.60 | |
| Mirati Therapeutics | 0.9 | $3.3M | 74k | 45.31 | |
| Axogen (AXGN) | 0.9 | $3.3M | 332k | 9.98 | |
| AtriCure (ATRC) | 0.9 | $3.2M | 72k | 44.38 | |
| Compass Therapeutics (CMPX) | 0.9 | $3.0M | 602k | 5.03 | |
| Arcus Biosciences Incorporated (RCUS) | 0.8 | $2.9M | 142k | 20.68 | |
| BioCryst Pharmaceuticals (BCRX) | 0.8 | $2.9M | 251k | 11.48 | |
| Mediwound Shs New (MDWD) | 0.8 | $2.8M | 204k | 13.49 | |
| Accuray Incorporated (ARAY) | 0.7 | $2.6M | 1.2M | 2.09 | |
| Century Therapeutics (IPSC) | 0.7 | $2.4M | 475k | 5.13 | |
| Mersana Therapeutics (MRSN) | 0.7 | $2.4M | 414k | 5.86 | |
| Galapagos Nv Spon Adr (GLPG) | 0.7 | $2.3M | 53k | 44.38 | |
| Autolus Therapeutics Spon Ads (AUTL) | 0.6 | $2.2M | 1.2M | 1.90 | |
| Neuronetics (STIM) | 0.6 | $2.2M | 314k | 6.87 | |
| Vigil Neuroscience (VIGL) | 0.6 | $2.1M | 169k | 12.50 | |
| Larimar Therapeutics (LRMR) | 0.6 | $2.0M | 473k | 4.13 | |
| Iteos Therapeutics (ITOS) | 0.5 | $1.9M | 99k | 19.53 | |
| Kura Oncology (KURA) | 0.5 | $1.8M | 145k | 12.41 | |
| Keros Therapeutics (KROS) | 0.4 | $1.6M | 33k | 48.02 | |
| Oric Pharmaceuticals (ORIC) | 0.4 | $1.6M | 264k | 5.89 | |
| Cymabay Therapeutics | 0.3 | $1.1M | 171k | 6.27 | |
| Syros Pharmaceuticals Com New (SYRS) | 0.3 | $955k | 266k | 3.59 | |
| Genfit S A Ads (GNFT) | 0.2 | $869k | 198k | 4.39 | |
| Affimed Therapeutics B V | 0.2 | $851k | 686k | 1.24 | |
| Mereo Biopharma Group Spon Ads (MREO) | 0.2 | $822k | 1.1M | 0.75 | |
| Pardes Biosciences | 0.2 | $810k | 479k | 1.69 | |
| Regulus Therapeutics (RGLS) | 0.2 | $761k | 556k | 1.37 | |
| Karyopharm Therapeutics (KPTI) | 0.2 | $655k | 193k | 3.40 | |
| Surface Oncology | 0.2 | $642k | 783k | 0.82 | |
| Cincor Pharma | 0.2 | $590k | 48k | 12.29 | |
| Brainsway Sponsored Ads (BWAY) | 0.2 | $543k | 220k | 2.47 | |
| Adaptimmune Therapeutics Sponds Adr (ADAP) | 0.1 | $513k | 351k | 1.46 | |
| Masimo Corporation (MASI) | 0.1 | $444k | 3.0k | 147.95 | |
| Kinnate Biopharma | 0.1 | $433k | 71k | 6.10 | |
| Theseus Pharmaceuticals | 0.1 | $408k | 82k | 4.98 | |
| Ikena Oncology (IKNA) | 0.1 | $326k | 123k | 2.66 | |
| Medicenna Therapeutics Corp. (MDNAF) | 0.1 | $302k | 660k | 0.46 | |
| Inogen (INGN) | 0.1 | $296k | 15k | 19.71 | |
| Biomea Fusion (BMEA) | 0.1 | $292k | 35k | 8.43 | |
| Macrogenics (MGNX) | 0.1 | $268k | 40k | 6.71 | |
| Nextcure (NXTC) | 0.1 | $265k | 188k | 1.41 | |
| Scynexis Com New (SCYX) | 0.1 | $239k | 153k | 1.56 | |
| Spero Therapeutics (SPRO) | 0.1 | $216k | 125k | 1.73 | |
| Acrivon Therapeutics Common Stock (ACRV) | 0.1 | $180k | 16k | 11.52 | |
| Black Diamond Therapeutics (BDTX) | 0.0 | $176k | 98k | 1.80 | |
| Lineage Cell Therapeutics In (LCTX) | 0.0 | $164k | 140k | 1.17 | |
| Compugen Ord (CGEN) | 0.0 | $147k | 205k | 0.72 | |
| Reunion Neuroscience | 0.0 | $43k | 48k | 0.90 | |
| Phasebio Pharmaceuticals | 0.0 | $9.7k | 322k | 0.03 |
